This paper describes the technology and early clinical development of the CAR T NKR-2 platform and elucidates its fundamental differences with classical CAR-T…

FDA

EuroBiotech Report: AstraZeneca rejection, Novartis phase 3 fail, $30M round, BioLineRx and Pierre Fabre

Medtronic's latest TAVR wins FDA nod

With eyes on FDA nod, Ivenix bags first of $50M for next-gen infusion pump